Global Primary Hyperoxaluria Drug Market Insights and Forecast to 2028

Global Primary Hyperoxaluria Drug Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Primary Hyperoxaluria Drug Product Introduction
1.2 Market by Type
1.2.1 Global Primary Hyperoxaluria Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 ALLN-230
1.2.3 DCR-PHXC
1.2.4 ALN-GO1
1.2.5 Others
1.3 Market by Application
1.3.1 Global Primary Hyperoxaluria Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Primary Hyperoxaluria Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Primary Hyperoxaluria Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Primary Hyperoxaluria Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Primary Hyperoxaluria Drug Sales by Region
2.4.1 Global Primary Hyperoxaluria Drug Sales by Region (2017-2022)
2.4.2 Global Sales Primary Hyperoxaluria Drug by Region (2023-2028)
2.5 Global Primary Hyperoxaluria Drug Revenue by Region
2.5.1 Global Primary Hyperoxaluria Drug Revenue by Region (2017-2022)
2.5.2 Global Primary Hyperoxaluria Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Primary Hyperoxaluria Drug Sales by Manufacturers
3.1.1 Global Top Primary Hyperoxaluria Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Primary Hyperoxaluria Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Primary Hyperoxaluria Drug in 2021
3.2 Global Primary Hyperoxaluria Drug Revenue by Manufacturers
3.2.1 Global Primary Hyperoxaluria Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Primary Hyperoxaluria Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Primary Hyperoxaluria Drug Revenue in 2021
3.3 Global Primary Hyperoxaluria Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Primary Hyperoxaluria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Primary Hyperoxaluria Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Primary Hyperoxaluria Drug Sales by Type
4.1.1 Global Primary Hyperoxaluria Drug Historical Sales by Type (2017-2022)
4.1.2 Global Primary Hyperoxaluria Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Primary Hyperoxaluria Drug Sales Market Share by Type (2017-2028)
4.2 Global Primary Hyperoxaluria Drug Revenue by Type
4.2.1 Global Primary Hyperoxaluria Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Primary Hyperoxaluria Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Primary Hyperoxaluria Drug Revenue Market Share by Type (2017-2028)
4.3 Global Primary Hyperoxaluria Drug Price by Type
4.3.1 Global Primary Hyperoxaluria Drug Price by Type (2017-2022)
4.3.2 Global Primary Hyperoxaluria Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Primary Hyperoxaluria Drug Sales by Application
5.1.1 Global Primary Hyperoxaluria Drug Historical Sales by Application (2017-2022)
5.1.2 Global Primary Hyperoxaluria Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Primary Hyperoxaluria Drug Sales Market Share by Application (2017-2028)
5.2 Global Primary Hyperoxaluria Drug Revenue by Application
5.2.1 Global Primary Hyperoxaluria Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Primary Hyperoxaluria Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Primary Hyperoxaluria Drug Revenue Market Share by Application (2017-2028)
5.3 Global Primary Hyperoxaluria Drug Price by Application
5.3.1 Global Primary Hyperoxaluria Drug Price by Application (2017-2022)
5.3.2 Global Primary Hyperoxaluria Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Primary Hyperoxaluria Drug Market Size by Type
6.1.1 North America Primary Hyperoxaluria Drug Sales by Type (2017-2028)
6.1.2 North America Primary Hyperoxaluria Drug Revenue by Type (2017-2028)
6.2 North America Primary Hyperoxaluria Drug Market Size by Application
6.2.1 North America Primary Hyperoxaluria Drug Sales by Application (2017-2028)
6.2.2 North America Primary Hyperoxaluria Drug Revenue by Application (2017-2028)
6.3 North America Primary Hyperoxaluria Drug Market Size by Country
6.3.1 North America Primary Hyperoxaluria Drug Sales by Country (2017-2028)
6.3.2 North America Primary Hyperoxaluria Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Primary Hyperoxaluria Drug Market Size by Type
7.1.1 Europe Primary Hyperoxaluria Drug Sales by Type (2017-2028)
7.1.2 Europe Primary Hyperoxaluria Drug Revenue by Type (2017-2028)
7.2 Europe Primary Hyperoxaluria Drug Market Size by Application
7.2.1 Europe Primary Hyperoxaluria Drug Sales by Application (2017-2028)
7.2.2 Europe Primary Hyperoxaluria Drug Revenue by Application (2017-2028)
7.3 Europe Primary Hyperoxaluria Drug Market Size by Country
7.3.1 Europe Primary Hyperoxaluria Drug Sales by Country (2017-2028)
7.3.2 Europe Primary Hyperoxaluria Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Primary Hyperoxaluria Drug Market Size by Type
8.1.1 Asia Pacific Primary Hyperoxaluria Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Primary Hyperoxaluria Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Primary Hyperoxaluria Drug Market Size by Application
8.2.1 Asia Pacific Primary Hyperoxaluria Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Primary Hyperoxaluria Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Primary Hyperoxaluria Drug Market Size by Region
8.3.1 Asia Pacific Primary Hyperoxaluria Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Primary Hyperoxaluria Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Primary Hyperoxaluria Drug Market Size by Type
9.1.1 Latin America Primary Hyperoxaluria Drug Sales by Type (2017-2028)
9.1.2 Latin America Primary Hyperoxaluria Drug Revenue by Type (2017-2028)
9.2 Latin America Primary Hyperoxaluria Drug Market Size by Application
9.2.1 Latin America Primary Hyperoxaluria Drug Sales by Application (2017-2028)
9.2.2 Latin America Primary Hyperoxaluria Drug Revenue by Application (2017-2028)
9.3 Latin America Primary Hyperoxaluria Drug Market Size by Country
9.3.1 Latin America Primary Hyperoxaluria Drug Sales by Country (2017-2028)
9.3.2 Latin America Primary Hyperoxaluria Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Primary Hyperoxaluria Drug Market Size by Type
10.1.1 Middle East and Africa Primary Hyperoxaluria Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Primary Hyperoxaluria Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Primary Hyperoxaluria Drug Market Size by Application
10.2.1 Middle East and Africa Primary Hyperoxaluria Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Primary Hyperoxaluria Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Primary Hyperoxaluria Drug Market Size by Country
10.3.1 Middle East and Africa Primary Hyperoxaluria Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Primary Hyperoxaluria Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allena Pharmaceuticals Inc
11.1.1 Allena Pharmaceuticals Inc Corporation Information
11.1.2 Allena Pharmaceuticals Inc Overview
11.1.3 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allena Pharmaceuticals Inc Recent Developments
11.2 Alnylam Pharmaceuticals Inc
11.2.1 Alnylam Pharmaceuticals Inc Corporation Information
11.2.2 Alnylam Pharmaceuticals Inc Overview
11.2.3 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Alnylam Pharmaceuticals Inc Recent Developments
11.3 Dicerna Pharmaceuticals Inc
11.3.1 Dicerna Pharmaceuticals Inc Corporation Information
11.3.2 Dicerna Pharmaceuticals Inc Overview
11.3.3 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dicerna Pharmaceuticals Inc Recent Developments
11.4 Intellia Therapeutics Inc
11.4.1 Intellia Therapeutics Inc Corporation Information
11.4.2 Intellia Therapeutics Inc Overview
11.4.3 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Intellia Therapeutics Inc Recent Developments
11.5 OxThera AB
11.5.1 OxThera AB Corporation Information
11.5.2 OxThera AB Overview
11.5.3 OxThera AB Primary Hyperoxaluria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 OxThera AB Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 OxThera AB Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Primary Hyperoxaluria Drug Industry Chain Analysis
12.2 Primary Hyperoxaluria Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Primary Hyperoxaluria Drug Production Mode & Process
12.4 Primary Hyperoxaluria Drug Sales and Marketing
12.4.1 Primary Hyperoxaluria Drug Sales Channels
12.4.2 Primary Hyperoxaluria Drug Distributors
12.5 Primary Hyperoxaluria Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Primary Hyperoxaluria Drug Industry Trends
13.2 Primary Hyperoxaluria Drug Market Drivers
13.3 Primary Hyperoxaluria Drug Market Challenges
13.4 Primary Hyperoxaluria Drug Market Restraints
14 Key Findings in The Global Primary Hyperoxaluria Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Primary Hyperoxaluria Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of ALLN-230
Table 3. Major Manufacturers of DCR-PHXC
Table 4. Major Manufacturers of ALN-GO1
Table 5. Major Manufacturers of Others
Table 6. Global Primary Hyperoxaluria Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Primary Hyperoxaluria Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Primary Hyperoxaluria Drug Sales by Region (2017-2022) & (K Pcs)
Table 9. Global Primary Hyperoxaluria Drug Sales Market Share by Region (2017-2022)
Table 10. Global Primary Hyperoxaluria Drug Sales by Region (2023-2028) & (K Pcs)
Table 11. Global Primary Hyperoxaluria Drug Sales Market Share by Region (2023-2028)
Table 12. Global Primary Hyperoxaluria Drug Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Primary Hyperoxaluria Drug Revenue Market Share by Region (2017-2022)
Table 14. Global Primary Hyperoxaluria Drug Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Primary Hyperoxaluria Drug Revenue Market Share by Region (2023-2028)
Table 16. Global Primary Hyperoxaluria Drug Sales by Manufacturers (2017-2022) & (K Pcs)
Table 17. Global Primary Hyperoxaluria Drug Sales Share by Manufacturers (2017-2022)
Table 18. Global Primary Hyperoxaluria Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Primary Hyperoxaluria Drug Revenue Share by Manufacturers (2017-2022)
Table 20. Primary Hyperoxaluria Drug Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 21. Global Primary Hyperoxaluria Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Primary Hyperoxaluria Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Hyperoxaluria Drug as of 2021)
Table 23. Primary Hyperoxaluria Drug Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Primary Hyperoxaluria Drug Product Offered
Table 25. Date of Manufacturers Enter into Primary Hyperoxaluria Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Primary Hyperoxaluria Drug Sales by Type (2017-2022) & (K Pcs)
Table 28. Global Primary Hyperoxaluria Drug Sales by Type (2023-2028) & (K Pcs)
Table 29. Global Primary Hyperoxaluria Drug Sales Share by Type (2017-2022)
Table 30. Global Primary Hyperoxaluria Drug Sales Share by Type (2023-2028)
Table 31. Global Primary Hyperoxaluria Drug Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Primary Hyperoxaluria Drug Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Primary Hyperoxaluria Drug Revenue Share by Type (2017-2022)
Table 34. Global Primary Hyperoxaluria Drug Revenue Share by Type (2023-2028)
Table 35. Primary Hyperoxaluria Drug Price by Type (2017-2022) & (USD/Pcs)
Table 36. Global Primary Hyperoxaluria Drug Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 37. Global Primary Hyperoxaluria Drug Sales by Application (2017-2022) & (K Pcs)
Table 38. Global Primary Hyperoxaluria Drug Sales by Application (2023-2028) & (K Pcs)
Table 39. Global Primary Hyperoxaluria Drug Sales Share by Application (2017-2022)
Table 40. Global Primary Hyperoxaluria Drug Sales Share by Application (2023-2028)
Table 41. Global Primary Hyperoxaluria Drug Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Primary Hyperoxaluria Drug Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Primary Hyperoxaluria Drug Revenue Share by Application (2017-2022)
Table 44. Global Primary Hyperoxaluria Drug Revenue Share by Application (2023-2028)
Table 45. Primary Hyperoxaluria Drug Price by Application (2017-2022) & (USD/Pcs)
Table 46. Global Primary Hyperoxaluria Drug Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 47. North America Primary Hyperoxaluria Drug Sales by Type (2017-2022) & (K Pcs)
Table 48. North America Primary Hyperoxaluria Drug Sales by Type (2023-2028) & (K Pcs)
Table 49. North America Primary Hyperoxaluria Drug Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Primary Hyperoxaluria Drug Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Primary Hyperoxaluria Drug Sales by Application (2017-2022) & (K Pcs)
Table 52. North America Primary Hyperoxaluria Drug Sales by Application (2023-2028) & (K Pcs)
Table 53. North America Primary Hyperoxaluria Drug Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Primary Hyperoxaluria Drug Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Primary Hyperoxaluria Drug Sales by Country (2017-2022) & (K Pcs)
Table 56. North America Primary Hyperoxaluria Drug Sales by Country (2023-2028) & (K Pcs)
Table 57. North America Primary Hyperoxaluria Drug Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Primary Hyperoxaluria Drug Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Primary Hyperoxaluria Drug Sales by Type (2017-2022) & (K Pcs)
Table 60. Europe Primary Hyperoxaluria Drug Sales by Type (2023-2028) & (K Pcs)
Table 61. Europe Primary Hyperoxaluria Drug Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Primary Hyperoxaluria Drug Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Primary Hyperoxaluria Drug Sales by Application (2017-2022) & (K Pcs)
Table 64. Europe Primary Hyperoxaluria Drug Sales by Application (2023-2028) & (K Pcs)
Table 65. Europe Primary Hyperoxaluria Drug Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Primary Hyperoxaluria Drug Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Primary Hyperoxaluria Drug Sales by Country (2017-2022) & (K Pcs)
Table 68. Europe Primary Hyperoxaluria Drug Sales by Country (2023-2028) & (K Pcs)
Table 69. Europe Primary Hyperoxaluria Drug Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Primary Hyperoxaluria Drug Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Primary Hyperoxaluria Drug Sales by Type (2017-2022) & (K Pcs)
Table 72. Asia Pacific Primary Hyperoxaluria Drug Sales by Type (2023-2028) & (K Pcs)
Table 73. Asia Pacific Primary Hyperoxaluria Drug Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Primary Hyperoxaluria Drug Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Primary Hyperoxaluria Drug Sales by Application (2017-2022) & (K Pcs)
Table 76. Asia Pacific Primary Hyperoxaluria Drug Sales by Application (2023-2028) & (K Pcs)
Table 77. Asia Pacific Primary Hyperoxaluria Drug Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Primary Hyperoxaluria Drug Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Primary Hyperoxaluria Drug Sales by Region (2017-2022) & (K Pcs)
Table 80. Asia Pacific Primary Hyperoxaluria Drug Sales by Region (2023-2028) & (K Pcs)
Table 81. Asia Pacific Primary Hyperoxaluria Drug Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Primary Hyperoxaluria Drug Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Primary Hyperoxaluria Drug Sales by Type (2017-2022) & (K Pcs)
Table 84. Latin America Primary Hyperoxaluria Drug Sales by Type (2023-2028) & (K Pcs)
Table 85. Latin America Primary Hyperoxaluria Drug Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Primary Hyperoxaluria Drug Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Primary Hyperoxaluria Drug Sales by Application (2017-2022) & (K Pcs)
Table 88. Latin America Primary Hyperoxaluria Drug Sales by Application (2023-2028) & (K Pcs)
Table 89. Latin America Primary Hyperoxaluria Drug Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Primary Hyperoxaluria Drug Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Primary Hyperoxaluria Drug Sales by Country (2017-2022) & (K Pcs)
Table 92. Latin America Primary Hyperoxaluria Drug Sales by Country (2023-2028) & (K Pcs)
Table 93. Latin America Primary Hyperoxaluria Drug Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Primary Hyperoxaluria Drug Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Primary Hyperoxaluria Drug Sales by Type (2017-2022) & (K Pcs)
Table 96. Middle East and Africa Primary Hyperoxaluria Drug Sales by Type (2023-2028) & (K Pcs)
Table 97. Middle East and Africa Primary Hyperoxaluria Drug Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Primary Hyperoxaluria Drug Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Primary Hyperoxaluria Drug Sales by Application (2017-2022) & (K Pcs)
Table 100. Middle East and Africa Primary Hyperoxaluria Drug Sales by Application (2023-2028) & (K Pcs)
Table 101. Middle East and Africa Primary Hyperoxaluria Drug Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Primary Hyperoxaluria Drug Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Primary Hyperoxaluria Drug Sales by Country (2017-2022) & (K Pcs)
Table 104. Middle East and Africa Primary Hyperoxaluria Drug Sales by Country (2023-2028) & (K Pcs)
Table 105. Middle East and Africa Primary Hyperoxaluria Drug Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Primary Hyperoxaluria Drug Revenue by Country (2023-2028) & (US$ Million)
Table 107. Allena Pharmaceuticals Inc Corporation Information
Table 108. Allena Pharmaceuticals Inc Description and Major Businesses
Table 109. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Allena Pharmaceuticals Inc Recent Developments
Table 112. Alnylam Pharmaceuticals Inc Corporation Information
Table 113. Alnylam Pharmaceuticals Inc Description and Major Businesses
Table 114. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Alnylam Pharmaceuticals Inc Recent Developments
Table 117. Dicerna Pharmaceuticals Inc Corporation Information
Table 118. Dicerna Pharmaceuticals Inc Description and Major Businesses
Table 119. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Dicerna Pharmaceuticals Inc Recent Developments
Table 122. Intellia Therapeutics Inc Corporation Information
Table 123. Intellia Therapeutics Inc Description and Major Businesses
Table 124. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 125. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Intellia Therapeutics Inc Recent Developments
Table 127. OxThera AB Corporation Information
Table 128. OxThera AB Description and Major Businesses
Table 129. OxThera AB Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 130. OxThera AB Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. OxThera AB Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Primary Hyperoxaluria Drug Distributors List
Table 135. Primary Hyperoxaluria Drug Customers List
Table 136. Primary Hyperoxaluria Drug Market Trends
Table 137. Primary Hyperoxaluria Drug Market Drivers
Table 138. Primary Hyperoxaluria Drug Market Challenges
Table 139. Primary Hyperoxaluria Drug Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Primary Hyperoxaluria Drug Product Picture
Figure 3. Global Primary Hyperoxaluria Drug Market Share by Type in 2021 & 2028
Figure 3. ALLN-230 Product Picture
Figure 4. DCR-PHXC Product Picture
Figure 5. ALN-GO1 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Primary Hyperoxaluria Drug Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Primary Hyperoxaluria Drug Report Years Considered
Figure 12. Global Primary Hyperoxaluria Drug Sales 2017-2028 (K Pcs)
Figure 13. Global Primary Hyperoxaluria Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Primary Hyperoxaluria Drug Revenue 2017-2028 (US$ Million)
Figure 15. Global Primary Hyperoxaluria Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Primary Hyperoxaluria Drug Sales Market Share by Region (2017-2022)
Figure 17. Global Primary Hyperoxaluria Drug Sales Market Share by Region (2023-2028)
Figure 18. North America Primary Hyperoxaluria Drug Sales YoY (2017-2028) & (K Pcs)
Figure 19. North America Primary Hyperoxaluria Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Primary Hyperoxaluria Drug Sales YoY (2017-2028) & (K Pcs)
Figure 21. Europe Primary Hyperoxaluria Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Primary Hyperoxaluria Drug Sales YoY (2017-2028) & (K Pcs)
Figure 23. Asia-Pacific Primary Hyperoxaluria Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Primary Hyperoxaluria Drug Sales YoY (2017-2028) & (K Pcs)
Figure 25. Latin America Primary Hyperoxaluria Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Primary Hyperoxaluria Drug Sales YoY (2017-2028) & (K Pcs)
Figure 27. Middle East & Africa Primary Hyperoxaluria Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Primary Hyperoxaluria Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Primary Hyperoxaluria Drug in the World: Market Share by Primary Hyperoxaluria Drug Revenue in 2021
Figure 30. Global Primary Hyperoxaluria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Primary Hyperoxaluria Drug Sales Market Share by Type (2017-2028)
Figure 32. Global Primary Hyperoxaluria Drug Revenue Market Share by Type (2017-2028)
Figure 33. Global Primary Hyperoxaluria Drug Sales Market Share by Application (2017-2028)
Figure 34. Global Primary Hyperoxaluria Drug Revenue Market Share by Application (2017-2028)
Figure 35. North America Primary Hyperoxaluria Drug Sales Market Share by Type (2017-2028)
Figure 36. North America Primary Hyperoxaluria Drug Revenue Market Share by Type (2017-2028)
Figure 37. North America Primary Hyperoxaluria Drug Sales Market Share by Application (2017-2028)
Figure 38. North America Primary Hyperoxaluria Drug Revenue Market Share by Application (2017-2028)
Figure 39. North America Primary Hyperoxaluria Drug Sales Share by Country (2017-2028)
Figure 40. North America Primary Hyperoxaluria Drug Revenue Share by Country (2017-2028)
Figure 41. U.S. Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Primary Hyperoxaluria Drug Sales Market Share by Type (2017-2028)
Figure 44. Europe Primary Hyperoxaluria Drug Revenue Market Share by Type (2017-2028)
Figure 45. Europe Primary Hyperoxaluria Drug Sales Market Share by Application (2017-2028)
Figure 46. Europe Primary Hyperoxaluria Drug Revenue Market Share by Application (2017-2028)
Figure 47. Europe Primary Hyperoxaluria Drug Sales Share by Country (2017-2028)
Figure 48. Europe Primary Hyperoxaluria Drug Revenue Share by Country (2017-2028)
Figure 49. Germany Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 50. France Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Primary Hyperoxaluria Drug Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Primary Hyperoxaluria Drug Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Primary Hyperoxaluria Drug Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Primary Hyperoxaluria Drug Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Primary Hyperoxaluria Drug Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Primary Hyperoxaluria Drug Revenue Share by Region (2017-2028)
Figure 60. China Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 63. India Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Primary Hyperoxaluria Drug Sales Market Share by Type (2017-2028)
Figure 71. Latin America Primary Hyperoxaluria Drug Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Primary Hyperoxaluria Drug Sales Market Share by Application (2017-2028)
Figure 73. Latin America Primary Hyperoxaluria Drug Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Primary Hyperoxaluria Drug Sales Share by Country (2017-2028)
Figure 75. Latin America Primary Hyperoxaluria Drug Revenue Share by Country (2017-2028)
Figure 76. Mexico Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Primary Hyperoxaluria Drug Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Primary Hyperoxaluria Drug Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Primary Hyperoxaluria Drug Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Primary Hyperoxaluria Drug Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Primary Hyperoxaluria Drug Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Primary Hyperoxaluria Drug Revenue Share by Country (2017-2028)
Figure 85. Turkey Primary Hyperoxaluria Drug Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Primary Hyperoxaluria Drug Revenue (20

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs